Browse the evidence

In nonobese women with PCOS, combining ethinylestradiol-drospirenone with flutamide-metformin reverts adipocytokine balance and body composition toward normal, improving long-term cardiovascular perspectives.

For women with PCOS who are at risk of pregnancy, combining a standard oral contraceptive (ethinylestradiol-drospirenone) with low-dose flutamide (62.5 mg) and metformin (850 mg) daily for 9 months can significantly improve body composition and metabolic markers. This approach offers the benefits of pregnancy protection along with the metabolic advantages of insulin sensitization and androgen blockade.

Liraglutide (3.0 mg) produces significant weight loss (-5.4% placebo-subtracted) and improves cardiovascular risk factors, but has a high discontinuation rate due to gastrointestinal side effects.

Liraglutide is a daily injection that helps lose about 5% more weight than placebo and improves heart health markers. However, it often causes nausea and vomiting, leading many patients to stop taking it.

High-calcium diets (≥1.2%) reduce adipocyte intracellular calcium, thereby suppressing lipogenesis and stimulating lipolysis, which accelerates fat loss during caloric restriction.

To maximize fat loss, ensure your diet provides about 1000mg of calcium daily, preferably from dairy sources like yogurt or milk, while maintaining a caloric deficit. This approach accelerates fat loss and specifically targets abdominal fat.

For very short bouts of physical activity (less than 1 minute), a minimum proportion of vigorous intensity (at least 12-15%) is required to significantly reduce the risk of Major Adverse Cardiovascular Events (MACE), though all-cause mortality benefits may appear at lower vigorous thresholds.

If you can only manage very short bursts of activity (under a minute), make sure they include some vigorous effort, like running up stairs quickly or walking very fast. This high-intensity component is crucial for protecting your heart when the duration is minimal.

Obesity-related sub-acute chronic inflammation acts as a pathologic mediator for both type 2 diabetes and atherosclerotic cardiovascular disease, with inflammatory markers like CRP predicting risk independently of weight.

If you have obesity or type 2 diabetes, your body's chronic low-grade inflammation is likely driving your risk for heart disease and worsening insulin resistance. While weight loss reduces this inflammation, specific anti-inflammatory strategies (like certain diabetes or cardiovascular drugs) may offer additional protection. Discuss with your doctor whether your current regimen addresses inflammatory risk, not just blood sugar or weight.

Acute vigorous submaximal exercise (67% VO2max for 60 minutes) significantly increases circulating GDF15 levels in humans, with levels continuing to rise during the recovery period.

Performing vigorous exercise (around 67% of your max capacity) for an hour triggers a significant rise in GDF15, a hormone linked to appetite suppression and energy balance. This rise continues for at least two hours after you stop exercising. While this doesn't mean your muscles are releasing the hormone directly, the systemic effect is real and substantial.

Night shift work and rapid time-zone changes disrupt circadian rhythms, leading to increased morbidity, mortality, and cognitive impairment.

If you work night shifts, use bright light exposure during your shift and wear blue-light-blocking glasses on your commute home. Prioritize a dark, quiet sleeping environment during the day. Be aware that long-term night work increases health risks, so monitor your health closely.

An acute bout of either endurance or resistance exercise significantly increases circulating levels of anabolic hormones (testosterone, estradiol, growth hormone) in females aged 19-69, regardless of chronological age.

If you are a woman between 19 and 69, doing a standard workout (either cardio or weights) will trigger a temporary spike in key anabolic hormones like testosterone and growth hormone. This happens regardless of your age, provided you are reasonably active. You don't need to be an elite athlete to get this hormonal response; typical recreational exercise intensities are sufficient.

Resistance exercise specifically increases Dehydroepiandrosterone (DHEA) levels, whereas endurance exercise does not significantly change DHEA in females.

If you are looking to boost DHEA specifically, resistance training (weights) appears to be the more effective modality compared to steady-state cardio. Endurance exercise did not significantly change DHEA levels in this study.

Daily consumption of 10g flaxseed mucilage for 6 weeks improves insulin sensitivity in obese postmenopausal women, evidenced by reduced serum C-peptide and insulin release during an oral glucose tolerance test and an increased Matsuda index.

If you are an obese postmenopausal woman, adding 10 grams of flaxseed mucilage to your daily diet (e.g., in breakfast buns) for 6 weeks can significantly improve your insulin sensitivity. This benefit occurs independently of increasing the abundance of common 'good' gut bacteria like Faecalibacterium, suggesting the mechanism may involve other metabolic pathways or short-chain fatty acid production not captured by simple bacterial counts.

Elevated circulating levels of branched-chain amino acids (BCAAs: valine, leucine, isoleucine) are positively associated with insulin resistance (IR) and predict a higher risk of developing type 2 diabetes.

High blood levels of BCAAs are a strong warning sign for developing type 2 diabetes, especially in overweight individuals. This is likely due to your body's reduced ability to process these amino acids (impaired catabolism) rather than just eating too much protein. Focus on improving metabolic health through weight management and exercise to enhance your body's ability to clear BCAAs, rather than fearing dietary protein.

Dietary protein and amino acids suppress food intake through redundant peripheral and central mechanisms, including vagal signaling via gut peptides (CCK, GLP-1, PYY) and central metabolic sensing (mTOR/AMPK) in the hypothalamus.

To leverage protein for appetite control, focus on its physiological effects rather than taste. Protein triggers gut hormones (CCK, GLP-1, PYY) and central brain sensors (mTOR/AMPK) that signal fullness. This is a robust biological mechanism, not just a matter of liking the food. Ensure your protein sources are well-balanced in essential amino acids to maximize this effect.

Leucine is a specific amino acid that modulates food intake centrally by activating mTOR and suppressing AMPK in the hypothalamus, mimicking the effects of high-protein diets.

Ensure your protein intake includes sufficient leucine, as it directly activates brain sensors (mTOR) that reduce hunger. This is a key driver of protein's satiating power, independent of total calories.

Fasting for 18 hours or more significantly reduces circulating PCSK9 levels in humans, independent of changes in LDL cholesterol.

Fasting for 18 hours or more significantly lowers circulating PCSK9, a protein that regulates LDL receptors. However, this does not necessarily translate to lower LDL cholesterol levels in the blood, as other regulatory mechanisms (like LDL receptor expression) may compensate. This suggests that PCSK9 levels alone are not a perfect predictor of LDL outcomes in fasting states.

Insulin resistance (IR) and hyperinsulinemia are key etiological components of PCOS that drive excessive ovarian androgen production, leading to reproductive dysfunction, independent of but amplified by obesity.

Understanding that insulin resistance drives PCOS symptoms is crucial. Treating insulin resistance through diet and lifestyle can help reduce androgen levels and restore ovulation, even without significant weight loss.

Evening chronotypes exhibit a significantly delayed subjective sleepiness rhythm (5–9 hours phase shift) compared to morning chronotypes, whereas endogenous circadian markers (core temperature and melatonin) show only a modest 2–3 hour delay, suggesting that subjective alertness drives sleep timing rather than biological phase alone.

If you are an evening type, your biological clock (melatonin/temperature) is only slightly delayed compared to morning people, but your feeling of sleepiness is delayed much more (5-9 hours). This mismatch causes you to stay up late not because your body demands it biologically, but because you don't feel sleepy. To fix this, you must align your bedtime with your biological ability to sleep (temperature/melatonin onset) rather than waiting until you feel subjectively sleepy, which happens too late for healthy sleep duration.

During submaximal exercise, low muscle glycogen levels increase fat oxidation primarily through heightened AMPK activation, whereas high glycogen levels limit fat oxidation by sequestering free carnitine into acetylcarnitine, despite similar malonyl-CoA reduction in both conditions.

To maximize fat oxidation during exercise, be aware that high muscle glycogen can limit fat burning by consuming free carnitine. While low glycogen boosts fat oxidation via AMPK, high glycogen creates a bottleneck where carnitine is used to buffer acetyl-CoA instead of transporting fat into mitochondria. Moderate intensity exercise with moderate glycogen may offer a balance, but very high intensity with high glycogen may shift fuel use toward carbohydrates due to this carnitine limitation.

Among adults aged 50–95, abdominal adiposity (measured by waist circumference) is a significantly stronger predictor of insulin resistance than cardiovascular fitness (VO2max) or whole-body adiposity (BMI/fat percentage).

If you are over 50, your waist size matters more for your blood sugar health than your cardio fitness level. While staying active is beneficial, focusing on reducing abdominal fat (measured by waist circumference) is the most effective way to lower insulin resistance risk. Do not assume high fitness cancels out the risks of a large waistline.

High work-related stress and increased workload cause a flattened diurnal cortisol pattern (specifically elevated evening levels) and reduced total sleep time, impairing physiological recovery.

If you are experiencing high work stress, expect your sleep to suffer and your stress hormones (cortisol) to remain elevated into the evening. This prevents proper physiological recovery. To mitigate this, you must actively create a buffer between work and sleep (e.g., no work after a specific time) to allow cortisol to drop and sleep duration to recover, as the body does not automatically 'switch off' under high workload.

Visceral fat mass exhibits the strongest positive correlation with insulin resistance (measured by HOMA-IR) among all adipose tissue depots and obesity indices.

If you are concerned about insulin resistance, looking at your weight (BMI) alone is not enough. Visceral fat (belly fat) is the strongest predictor of metabolic risk. Even if your BMI is normal, high visceral fat can lead to insulin resistance. Prioritize measuring waist circumference or assessing body composition over BMI alone for metabolic health assessment.

Regular aerobic exercise increases HDL cholesterol levels and enhances Reverse Cholesterol Transport (RCT) efficiency by upregulating key receptors (ABCA1, ABCG1, SR-B1) and enzymes (LCAT, CETP).

Engage in regular aerobic exercise, such as walking or cycling. You do not need extreme intensity; even moderate activities like walking 10,000 steps three times a week can improve your HDL cholesterol and overall lipid profile. Consistency is key, and combining aerobic with resistance training may offer additional benefits.

Bright light exposure (>10,000 lux) timed to follow the core body temperature minimum successfully advances the circadian phase of melatonin and cortisol by approximately 8-10 hours.

To shift your body clock earlier (e.g., for morning shifts), expose yourself to very bright light (>10,000 lux) for several hours starting shortly after you wake up. This is significantly more effective than normal room lighting. Ensure the light is safe for your eyes (use filtered devices) and avoid bright light in the evening.

Immediate-release melatonin at moderate doses effectively reduces sleep onset latency and improves symptoms associated with poorly coupled circadian rhythms, such as seasonal affective and bipolar disorders.

If you struggle with falling asleep or have seasonal mood shifts, immediate-release melatonin at a moderate dose is a valid, evidence-backed option. It works by signaling your brain that it is night, helping to reset your internal clock and initiate sleep.

Prolonged-release melatonin or synthetic agonists are required for replacement therapy aimed at maintaining sleep throughout the night, as immediate-release formulations are insufficient for sleep maintenance.

If you fall asleep easily but wake up frequently or early, immediate-release melatonin may not be enough. You may benefit from prolonged-release formulations or synthetic agonists designed to sustain melatonin signaling throughout the night.